The DOI matches its Crossref record.
CD105 antagonizes the inhibitory signaling of transforming growth factor βl on human vascular endothelial cells
Abstract
CD105 (endoglin), a receptor for transforming growth factor β (TGFβ), is highly expressed in tissue‐cultured, activated endothelial cells in vitro and in tissues undergoing angiogenesis in vivo. The absence of CD105 in knockout mice leads to their death from defective vascular development, but the role of CD105 in the modulation of angiogenesis has not been elucidated. TGFβ1isa well‐recognized regulator of angiogenesis. Using an antisense approach, we have shown that inhibition of CD105 protein translation in cultured human endothelial cells enhances the ability of TGFβ1 to suppress growth and migration in these cells. The ability of endothelial cells to form capillary tubes was evaluated by the use of a 3‐dimensional collagen matrix system where TGFβ 1 not only reduced the length of capillary‐like structures, but also caused massive mortality in CD105‐deficient cells compared to control cultures. These results provide direct evidence that CD105 antagonizes the inhibitory effects of TGFβ1 on human vascular endothelial cells and that normal cellular levels of CD105 are required for the formation of new blood vessels.—Li, C., Hampson, I. N., Hampson, L., Kumar, P., Bernabeu, C., Kumar, S. CD105 antagonizes the inhibitory signaling of transforming growth factor b1 on human vascular endothelial cells. FASEB J . 14, 55–64(1999)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors
Goumans, M.-J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1743 · Cited by 1,123
Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction
Lebrin, F., Goumans, M., Jonker, L., Carvalho, R. L., Valdimarsdottir, G., Thorikay, M., Mummery, C., Arthur, H. M., & Dijke, P. T. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600386 · Cited by 652
CD105 is important for angiogenesis: evidence and potential applications
DUFF, S. E., LI, C., GARLAND, J. M., & KUMAR, S. (2003) · The FASEB Journal · doi:10.1096/fj.02-0634rev · Cited by 556
Self-citationThe Role of Angiogenesis in Hepatocellular Carcinoma
Morse, M. A., Sun, W., Kim, R., He, A. R., Abada, P. B., Mynderse, M., & Finn, R. S. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1254 · Cited by 533
TGF-? receptor function in the endothelium
LEBRIN, F., DECKERS, M., BERTOLINO, P., & TENDIJKE, P. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.10.036 · Cited by 513
Resting and activated endothelial cells are increased in the peripheral blood of cancer patients
Mancuso, P., Burlini, A., Pruneri, G., Goldhirsch, A., Martinelli, G., & Bertolini, F. (2001) · Blood · doi:10.1182/blood.v97.11.3658 · Cited by 421
Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy
Dallas, N. A., Samuel, S., Xia, L., Fan, F., Gray, M. J., Lim, S. J., & Ellis, L. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4478 · Cited by 359
Controlling the Angiogenic Switch
Goumans, M.-J., Lebrin, F., & Valdimarsdottir, G. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(03)00142-7 · Cited by 338
Endoglin in angiogenesis and vascular diseases
ten Dijke, P., Goumans, M.-J., & Pardali, E. (2008) · Angiogenesis · doi:10.1007/s10456-008-9101-9 · Cited by 327
Sánchez-Elsner, T., Botella, L. M., Velasco, B., Langa, C., & Bernabéu, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207160200 · Cited by 326
Welt, C., Sidis, Y., Keutmann, H., & Schneyer, A. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700905 · Cited by 324
Molecular Determinants of Ovarian Cancer Plasticity
Sood, A. K., Seftor, E. A., Fletcher, M. S., Gardner, L. M. G., Heidger, P. M., Buller, R. E., Seftor, R. E. B., & Hendrix, M. J. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64079-5 · Cited by 268
Cytokines and Immune Response in the Tumor Microenvironment
Mocellin, S., Wang, E., & Marincola, F. M. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200109000-00002 · Cited by 259
The emerging role of TGF-β superfamily coreceptors in cancer
Bernabeu, C., Lopez-Novoa, J. M., & Quintanilla, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.003 · Cited by 254
Self-citationTGF-β family co-receptor function and signaling
Nickel, J., Ten Dijke, P., & Mueller, T. D. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx126 · Cited by 198
Awwad, K., Hu, J., Shi, L., Mangels, N., Abdel Malik, R., Zippel, N., Fisslthaler, B., Eble, J. A., Pfeilschifter, J., Popp, R., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv098 · Cited by 77
Microphysiological model of renal cell carcinoma to inform anti-angiogenic therapy
Virumbrales-Muñoz, M., Ayuso, J. M., Loken, J. R., Denecke, K. M., Rehman, S., Skala, M. C., Abel, E. J., & Beebe, D. J. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121454 · Cited by 20
Metadata
- Authors
- LI, C., HAMPSON, I. N., HAMPSON, L., KUMAR, P., BERNABEU, C., & KUMAR, S.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2000-01
- Volume
- 14
- Issue
- 1
- Pages
- 55-64
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1520156967
- Cited by
- 230
- References
- 0
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.